GBUK and ABHI building relationships in Saudi

GBUK is expanding its international footprint, bringing high-quality medical devices and innovative technologies to new regions around the world.

As part of this strategic growth, we’ve enrolled in the 12 month ABHI Middle East Accelerator Programme, supporting our ongoing work in the Kingdom of Saudi Arabia and furthering our ambitions in the wider GCC region.

Why Saudi?

We have already seen promising progress in the region, with a good level of sales in UAE, Qatar and Saudi already, and believe there is considerable potential for further development. The decision to join the ABHI Accelerator Programme builds on our current momentum and provides a structured platform to strengthen our presence and nurture relationships in the Kingdom.

Saudi Arabia is undergoing a significant transformation in its healthcare sector, aligned with the national Vision 2030 strategy. With an emphasis on innovation, quality and long-term sustainability, Saudi is investing heavily in infrastructure, digital health and clinical excellence. There is also a high regard held for British healthcare. This correlates with our own values and expertise, making it an ideal time to support the country’s ambitions with our proven technologies.

Our objectives

Through our participation in the Accelerator Programme, we aim to achieve several key objectives:

  • Develop a more detailed understanding of the healthcare landscape across Saudi Arabia and the broader MENA region, including current transitions and future direction.
  • Build relationships with key stakeholders, including the Ministry of Health, Saudi Food and Drug Authority (SFDA), NUPCO and leading private healthcare groups.
  • Identify potential distribution partners who can support the growth of our expanding product portfolio in the region.
  • Visit leading hospitals and clinical centres to explore how GBUK’s technologies can positively influence care delivery, and how best we can support our local partners.

Our visits to Saudi

The ABHI programme has already delivered a range of valuable activities, including expert sessions, networking opportunities and in-market missions.

One of two scheduled mission weeks took place earlier in the spring. We had the privilege of meeting with a number of incredible people and influential organisations, including Dr Sulaiman Al Habib Hospitals, King Faisal Hospital, National Guard Hospital, Ministry of Health, Ministry of Investment and the Saudi Food and Drug Authority.

These meetings offered important insights into current healthcare priorities within Saudi Arabia. They also confirmed a clear demand for the kind of clinically effective, reliable technologies GBUK is known for.

October saw the second visit to the Kingdom for GBUK in the past 12 months, showcasing the group’s expanding portfolio and accompanying partnership opportunities, at one of the fastest growing medical device exhibitions in the world.

The event was a valuable opportunity to meet new and existing stakeholders in both the public and private sectors in Saudi Arabia; from NUPCO to our existing distribution partners Medicine Glories Company.

What’s clear from both time at the exhibition, and time in a number of medical institutions across Riyadh and Jeddah, is the continuing need for high quality, price competitive medical devices. The ABHI mission has helped the team truly understand the health ecosystem in Saudi Arabia, and clearly identified the priorities GBUK will focus on as we look to continue our growth and presence across MENA.